{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:16:30Z","timestamp":1783476990456,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,7]]},"DOI":"10.7759\/cureus.112237","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:36:15Z","timestamp":1783474575000},"source":"Crossref","is-referenced-by-count":0,"title":["Delayed Recognition of Glycoprotein IIb\/IIIa Antibody-Associated Platelet Dysfunction in Chronic Liver Disease: A Platelet-Mediated Bleeding-Thrombosis Dysregulation"],"prefix":"10.7759","author":[{"given":"Niyas Khalid","family":"Ottu Para","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Rab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000103655","article-title":"Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment","volume":"24","author":"Lisman T","year":"2007","unstructured":"Lisman T, Leebeek FW. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg. 2007, 24:250-8. 10.1159\/000103655","journal-title":"Dig Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-261891","article-title":"Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences","volume":"116","author":"Lisman T","year":"2010","unstructured":"Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood. 2010, 116:878-85. 10.1182\/blood-2010-02-261891","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi A","year":"2011","unstructured":"Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011, 365:147-56. 10.1056\/NEJMra1011170","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.02.026","article-title":"Coagulation in liver disease: a guide for the clinician","volume":"11","author":"Northup PG","year":"2013","unstructured":"Northup PG, Caldwell SH. Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol. 2013, 11:1064-74. 10.1016\/j.cgh.2013.02.026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.234S","article-title":"Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Patrono C","year":"2004","unstructured":"Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004, 126:234S-64S. 10.1378\/chest.126.3_suppl.234S","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2515","article-title":"Arterial thrombosis--insidious, unpredictable and deadly","volume":"17","author":"Jackson SP","year":"2011","unstructured":"Jackson SP. Arterial thrombosis--insidious, unpredictable and deadly. Nat Med. 2011, 17:1423-36. 10.1038\/nm.2515","journal-title":"Nat Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction","volume":"72","author":"Thygesen K","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. Fourth universal definition of myocardial infarction. J Am Coll Cardiol. 2018, 72:2231-64. 10.1016\/j.jacc.2018.08.1038","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.02.018","article-title":"Type 2 myocardial infarction: JACC review topic of the week","volume":"73","author":"Sandoval Y","year":"2019","unstructured":"Sandoval Y, Jaffe AS. Type 2 myocardial infarction: JACC review topic of the week. J Am Coll Cardiol. 2019, 73:1846-60. 10.1016\/j.jacc.2019.02.018","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anemia and iron deficiency in heart failure: current concepts and emerging therapies","volume":"138","author":"Anand IS","year":"2018","unstructured":"Anand IS, Gupta P. Anemia and iron deficiency in heart failure: current concepts and emerging therapies. Circulation. 2018, 138:80-98. 10.1161\/CIRCULATIONAHA.118.030099","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.01.010","article-title":"Haemostasis in cirrhosis: understanding destabilising factors during acute decompensation","volume":"78","author":"Zanetto A","year":"2023","unstructured":"Zanetto A, Northup P, Roberts L, Senzolo M. Haemostasis in cirrhosis: understanding destabilising factors during acute decompensation. J Hepatol. 2023, 78:1037-47. 10.1016\/j.jhep.2023.01.010","journal-title":"J Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.279751","article-title":"Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia","volume":"107","author":"Zheng SS","year":"2022","unstructured":"Zheng SS, Ahmadi Z, Leung HH, Wong R, Yan F, Perdomo JS, Chong BH. Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia. Haematologica. 2022, 107:2195-205. 10.3324\/haematol.2021.279751","journal-title":"Haematologica"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31507","article-title":"VWF\/ADAMTS13 imbalance, but not global coagulation or fibrinolysis, is associated with outcome and bleeding in acute liver failure","volume":"73","author":"Driever EG","year":"2021","unstructured":"Driever EG, Stravitz RT, Zhang J, Adelmeijer J, Durkalski V, Lee WM, Lisman T. VWF\/ADAMTS13 imbalance, but not global coagulation or fibrinolysis, is associated with outcome and bleeding in acute liver failure. Hepatology. 2021, 73:1882-91. 10.1002\/hep.31507","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-023-10577-y","article-title":"Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome","volume":"17","author":"Simbrunner B","year":"2023","unstructured":"Simbrunner B, Villesen IF, Scheiner B, et al.. Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome. Hepatol Int. 2023, 17:1532-44. 10.1007\/s12072-023-10577-y","journal-title":"Hepatol Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al.. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022, 79:1757-80. 10.1016\/j.jacc.2021.12.011","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.10.027","article-title":"Gastrointestinal injury caused by aspirin or clopidogrel monotherapy versus dual antiplatelet therapy","volume":"79","author":"Bittl JA","year":"2022","unstructured":"Bittl JA, Laine L. Gastrointestinal injury caused by aspirin or clopidogrel monotherapy versus dual antiplatelet therapy. J Am Coll Cardiol. 2022, 79:129-31. 10.1016\/j.jacc.2021.10.027","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2526","article-title":"Clinical pharmacogenetics implementation consortium guideline for CYP2C19 genotype and clopidogrel therapy: 2022 update","volume":"112","author":"Lee CR","year":"2022","unstructured":"Lee CR, Luzum JA, Sangkuhl K, et al.. Clinical pharmacogenetics implementation consortium guideline for CYP2C19 genotype and clopidogrel therapy: 2022 update. Clin Pharmacol Ther. 2022, 112:959-67. 10.1002\/cpt.2526","journal-title":"Clin Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001627","article-title":"American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: management of anticoagulants and antiplatelets during acute gastrointestinal bleeding and the periendoscopic period","volume":"117","author":"Abraham NS","year":"2022","unstructured":"Abraham NS, Barkun AN, Sauer BG, et al.. American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: management of anticoagulants and antiplatelets during acute gastrointestinal bleeding and the periendoscopic period. Am J Gastroenterol. 2022, 117:542-58. 10.14309\/ajg.0000000000001627","journal-title":"Am J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001558","article-title":"Antiplatelet medications are associated with bleeding and decompensation events among patients with cirrhosis","volume":"56","author":"Lieber SR","year":"2022","unstructured":"Lieber SR, Jiang Y, Moon A, Barritt AS. Antiplatelet medications are associated with bleeding and decompensation events among patients with cirrhosis. J Clin Gastroenterol. 2022, 56:627-34. 10.1097\/MCG.0000000000001558","journal-title":"J Clin Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/505773-delayed-recognition-of-glycoprotein-iibiiia-antibody-associated-platelet-dysfunction-in-chronic-liver-disease-a-platelet-mediated-bleeding-thrombosis-dysregulation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:36:17Z","timestamp":1783474577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/505773-delayed-recognition-of-glycoprotein-iibiiia-antibody-associated-platelet-dysfunction-in-chronic-liver-disease-a-platelet-mediated-bleeding-thrombosis-dysregulation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.112237","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,7]]}}}